XML 41 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2016
Share-based Compensation [Abstract]  
Schedule of Stock-Based Compensation Expense Recognized in our Condensed Consolidated Statements of Income
The following table sets forth the stock-based compensation expense recognized in our Condensed Consolidated Statements of Operations:
 
Three Months Ended
 
Six Months Ended
 
September 30, 2016
 
October 2,
2015
 
September 30, 2016
 
October 2,
2015
 
(In millions)
Cost of revenues
$
5

 
$
2

 
$
8

 
$
4

Sales and marketing
24

 
16

 
38

 
27

Research and development
24

 
16

 
39

 
28

General and administrative
32

 
11

 
49

 
21

Total stock-based compensation expense
85

 
45

 
134

 
80

Tax benefit associated with stock-based compensation expense
(25
)
 
(13
)
 
(40
)
 
(23
)
Net stock-based compensation expense from continuing operations
60

 
32

 
94

 
57

Net stock-based compensation expense from discontinued operations

 
24

 

 
37

Net stock-based compensation expense
$
60

 
$
56

 
$
94

 
$
94

Schedule of Additional Information Related to Stock-Based Compensation
The following table summarizes additional information related to our stock-based compensation:
 
Six Months Ended
 
September 30, 2016
 
October 2,
2015
 
(In millions, except per grant data)
Restricted stock units
 
 
 
Weighted-average fair value per grant
$
18.59

 
$
23.53

Awards granted and assumed in acquisition
13.8

 
12.8

Total fair value of awards vested
$
94

 
$
140

Total unrecognized compensation expense
$
301

 
$
462

Weighted-average remaining vesting period
2.1 years

 
2.3 years

Performance-based restricted stock units
 
 
 
Weighted-average fair value per grant
$
19.84

 
$
27.03

Awards granted and assumed in acquisition
4.9

 
0.9

Total fair value of awards released
$
13

 
$
5

Total unrecognized compensation expense
$
68

 
$
24

Weighted-average remaining vesting period
1.4 years

 
1.8 years

Stock options

 

Total intrinsic value of stock options exercised
$
50

 
$
2

Total unrecognized compensation expense
$
134

 
$

Weighted-average remaining vesting period
1.8 years